Jeffrey B. Kindler
Director · PRECIGEN, INC.
IndividualSelling only
- 2024
- Aug 29, 2026
- 12
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Jeffrey B. Kindler files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Randal J. Kirk - $28.04M in PGEN purchases and sales in the last 12 months
- Helen Sabzevari - $2.56M in PGEN purchases and sales in the last 12 months
- Harry Thomasian Jr. - $1.90M in PGEN purchases and sales in the last 12 months
- Rutul R. Shah - $1.26M in PGEN purchases and sales in the last 12 months
- Phil Tennant - $726K in PGEN purchases and sales in the last 12 months
- Donald P. Lehr - $127K in PGEN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Jeffrey B. Kindler?
Jeffrey B. Kindler is a corporate insider, tracked as Director of PRECIGEN, INC. (PGEN). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Jeffrey B. Kindler submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Jeffrey B. Kindler been buying or selling stock?
Recorded transactions: 0 open-market purchases and 5 open-market sales ($3.33M) across all tracked filings.
